-DOCSTART- -X- O
Abstract -X- _ O
Adoptive -X- _ O
immunotherapy—in -X- _ O
particular -X- _ O
, -X- _ O
T-cell -X- _ B-Intervention
therapy—has -X- _ I-Intervention
recently -X- _ O
emerged -X- _ O
as -X- _ O
a -X- _ O
useful -X- _ B-Outcome
strategy -X- _ I-Outcome
with -X- _ I-Outcome
the -X- _ I-Outcome
potential -X- _ I-Outcome
to -X- _ I-Outcome
overcome -X- _ I-Outcome
many -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
limitations -X- _ I-Outcome
of -X- _ I-Outcome
antiviral -X- _ I-Outcome
drugs -X- _ I-Outcome
for -X- _ I-Outcome
the -X- _ I-Outcome
treatment -X- _ I-Outcome
of -X- _ I-Outcome
viral -X- _ I-Outcome
complications -X- _ I-Outcome
after -X- _ I-Outcome
hematopietic -X- _ I-Outcome
stem -X- _ I-Outcome
cell -X- _ I-Outcome
transplantation. -X- _ I-Outcome
In -X- _ O
this -X- _ O
review -X- _ O
, -X- _ O
we -X- _ O
briefly -X- _ O
summarize -X- _ O
the -X- _ O
current -X- _ O
methods -X- _ O
for -X- _ O
virus-specific -X- _ O
T-cell -X- _ O
isolation -X- _ O
or -X- _ O
selection -X- _ O
and -X- _ O
we -X- _ O
report -X- _ O
results -X- _ O
from -X- _ O
clinical -X- _ O
trials -X- _ O
that -X- _ O
have -X- _ O
used -X- _ O
these -X- _ O
techniques -X- _ O
, -X- _ O
focusing -X- _ O
specifically -X- _ O
on -X- _ O
the -X- _ O
strategies -X- _ O
aimed -X- _ O
to -X- _ O
broaden -X- _ O
the -X- _ O
application -X- _ O
of -X- _ O
this -X- _ O
technology -X- _ O
. -X- _ O

